Bank of New York Mellon’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.58M Buy
315,934
+10,378
+3% +$102K ﹤0.01% 2642
2026
Q1
$1.93M Sell
305,556
-32,892
-10% -$296K ﹤0.01% 2829
2025
Q4
$3.62M Sell
338,448
-38,172
-10% -$419K ﹤0.01% 2503
2025
Q3
$4.69M Sell
376,620
-2,927
-0.8% -$30K ﹤0.01% 2359
2025
Q2
$3.88M Buy
379,547
+194,042
+105% +$1.71M ﹤0.01% 2411
2025
Q1
$1.47M Buy
185,505
+3,062
+2% +$37.7K ﹤0.01% 2834
2024
Q4
$1.43M Buy
182,443
+47,312
+35% +$237K ﹤0.01% 2920
2024
Q3
$426K Sell
135,131
-45,040
-25% -$132K ﹤0.01% 3603
2024
Q2
$510K Sell
180,171
-299,903
-62% -$2.14M ﹤0.01% 3578
2024
Q1
$7.56M Buy
480,074
+26,328
+6% +$445K ﹤0.01% 2110
2023
Q4
$8.92M Sell
453,746
-3,036
-0.7% -$52.7K ﹤0.01% 2038
2023
Q3
$9.3M Buy
456,782
+2,429
+0.5% +$61.1K ﹤0.01% 1983
2023
Q2
$13.3M Buy
454,353
+76,545
+20% +$2.1M ﹤0.01% 1790
2023
Q1
$10.6M Sell
377,808
-1,555
-0.4% -$39.9K ﹤0.01% 1911
2022
Q4
$7.03M Sell
379,363
-770
-0.2% -$13.2K ﹤0.01% 2137
2022
Q3
$5.99M Sell
380,133
-29,244
-7% -$657K ﹤0.01% 2195
2022
Q2
$10.3M Sell
409,377
-49,824
-11% -$1.49M ﹤0.01% 1914
2022
Q1
$16.6M Buy
459,201
+37,635
+9% +$1.85M ﹤0.01% 1783
2021
Q4
$32.3M Sell
421,566
-7,806
-2% -$688K 0.01% 1429
2021
Q3
$41.3M Buy
429,372
+231,517
+117% +$25.3M 0.01% 1262
2021
Q2
$21.1M Sell
197,855
-34,056
-15% -$3.35M ﹤0.01% 1706
2021
Q1
$20.8M Sell
231,911
-21,263
-8% -$2.34M ﹤0.01% 1689
2020
Q4
$25.4M Buy
253,174
+4,777
+2% +$356K 0.01% 1504
2020
Q3
$12.1M Buy
248,397
+24,932
+11% +$1.2M ﹤0.01% 1749
2020
Q2
$9.13M Buy
223,465
+81,664
+58% +$2.35M ﹤0.01% 1883
2020
Q1
$2.18M Sell
141,801
-13,572
-9% -$285K ﹤0.01% 2505
2019
Q4
$3.52M Buy
+155,373
New +$2.55M ﹤0.01% 2518

Other funds holding CRNC

Bank of New York Mellon's CRNC Position: Q2 2026 in Review

Bank of New York Mellon increased its Cerence (CRNC) stake by 3.4% in Q2 2026, buying an estimated $102K and bringing the position to 315,934 shares worth $3.58M. The position accounts for ﹤0.01% of the portfolio, ranked #2642.

Bank of New York Mellon first reported a position in CRNC in Q4 2019 and has held it in 27 quarters since. The position peaked at $41.3M in Q3 2021. 93 funds tracked by Wall St. Rank hold CRNC as of Q2 2026.

  • Bank of New York Mellon held 315,934 shares of Cerence worth $3.58M as of Q2 2026.
  • Bank of New York Mellon bought 10,378 Cerence shares in Q2 2026, an estimated $102K.
  • Cerence made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2642 holding.
  • Bank of New York Mellon first reported a position in Cerence in Q4 2019 and has held it in 27 quarters since.
  • Bank of New York Mellon's Cerence position peaked at $41.3M in Q3 2021.
  • 93 funds tracked by Wall St. Rank held Cerence as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.